Anavex Presents Compelling Data at World’s Largest Alzheimer’s Conference

Anavex to Present at Alzheimer’s Association International Conference

Anavex Appoints Robert Chisholm as CFO

Anavex Comments on President Obama’s National Plan to Fight Alzheimer’s Disease

Anavex to Present Corporate Update at BIO CEO & Investor Conference

Anavex Successfully Completes a Phase 1 Clinical Trial for ANAVEX 2-73

Anavex Appoints Dr. George Tidmarsh as Executive Director

Anavex Announces Director Resignation

Anavex to Present Data on ANAVEX 2-73, Lead Compound for Alzheimer’s Disease, at Japan Neuroscience Society Special Symposium

Anavex Presents Data on Neuroprotective Evidence for ANAVEX 2-73, Lead Compound for Alzheimer’s Disease